Mackay Shields LLC’s MiMedx Group MDXG Stock Holding History

Mackay Shields LLC’s Portfolio MDXG Stock Details MDXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-60,332	Closed	-$421K	–	1256
2018 Q1	$421K	Buy	+60,332	New	+$702K	﹤0.01%	1143

Other funds holding MDXG

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

Tiedemann Advisors New York $2.33B AUM 15.56% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Mackay Shields LLC's MDXG Position: Q2 2018 in Review

Mackay Shields LLC sold out of MiMedx Group (MDXG) in Q2 2018, closing a stake of 60,332 shares — an estimated $421K sold.

Mackay Shields LLC first reported a position in MDXG in Q1 2018 and held it in 1 quarter. The position peaked at $421K in Q1 2018. 213 funds tracked by Wall St. Rank hold MDXG as of Q2 2018.

Mackay Shields LLC reported no remaining MiMedx Group position as of Q2 2018 after selling out during the quarter.
Mackay Shields LLC sold 60,332 MiMedx Group shares in Q2 2018, an estimated $421K.
Mackay Shields LLC first reported a position in MiMedx Group in Q1 2018 and held it in 1 quarter.
Mackay Shields LLC's MiMedx Group position peaked at $421K in Q1 2018.
213 funds tracked by Wall St. Rank held MiMedx Group as of Q2 2018.

Based on Mackay Shields LLC's 13F filing for Q2 2018, filed 6 Aug 2018.